26 results
Therapeutic Indications for the Anticonvulsant Agents

#Anticonvulsant #Antiseizure #Medications #Pharmacology #Table #Neurology #Epilepsy #Management
Therapeutic Indications ... Anticonvulsant Agents ... #Antiseizure #Medications ... #Pharmacology #Table ... Neurology #Epilepsy #Management
Oral anti-hypertensives with relative fast onset of action (Hypertensive Emergency)

The key concern with oral antihypertensive agents
antihypertensive agents ... allow one dose of medication ... antihypertensive agent ... Hypertensive #Emergency #Management ... #Pharmacology #Table
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Assessment and Management ... Non-Opioid Analgesics - Agents ... and Dosing #Management ... NonOpioid #Analgesics #Medications ... Doses #Dosing #Table
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Assessment and Management ... Muscle Relaxants - Agents ... and Dosing #Management ... Relaxers #Relaxants #Medications ... Doses #Dosing #Table
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
anti-hyperglycemic agents ... Each class of medications ... pharmacotherapy #table ... #comparison #management ... #medications #diabetes
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
Assessment and Management ... Neuropathic Pain Medications ... : Agent, Initiation ... #Neuropathic #Medications ... Doses #Dosing #Table
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Assessment and Management ... Distribution, Agents ... and Dosing Table ... Nerve #Blocks #Medications ... Doses #Dosing #Table
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... #diabetes #medications ... #table #comparison ... #management #endocrinology
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Overview of Treatment Agents ... 2020 #Drugs #Medications ... #Pharmacology #Table ... #Management #MGH
HIV Antiretroviral Regimen Components 
Dual NRTI Backbone + Third Agent 

The general HIV antiretroviral medication regimen
Backbone + Third Agent ... antiretroviral medication ... now 10 single-tablet ... product is just 1 tablet ... #Pharmacology #Management